Search

Your search keyword '"Pettaway, C"' showing total 170 results
Start Over Author "Pettaway, C"
170 results on '"Pettaway, C"'

1. Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus

Author

Sotelo, R, Sayegh, A, Medina, L, Perez, L, Riva, A, Eppler, M, Gaona, J, Tobias-Machado, M, Spiess, P, Pettaway, C, Pompeo, A, Mattos, P, Wilson, T, Villoldo, G, Chung, E, Samaniego, A, Ornellas, A, Pinheiro, V, Brazão, E, Subira-Rios, D, Koifman, L, de Cassio Zequi, S, Pontillo, H, de Ribamar Rodrigues Calixto, J, Silva, R, Mark Smithers, B, Garzon, S, Haase, O, Sommariva, A, Fruscio, R, Martins, F, de Oliveira, P, Sandri, G, Clementi, M, Astigueta, J, Metwally, I, Bharathan, R, Jindal, T, Nakamura, Y, Mageed, H, Jeevarajan, S, Lay, R, García-Perdomo, H, González, O, Ghodoussipour, S, Gill, I, Cacciamani, G, Sotelo R., Sayegh A. S., Medina L. G., Perez L. C., Riva A. L., Eppler M. B., Gaona J., Tobias-Machado M., Spiess P. E., Pettaway C. A., Pompeo A. C. L., Mattos P. A. L., Wilson T. G., Villoldo G. M., Chung E., Samaniego A., Ornellas A. A., Pinheiro V., Brazão E. S., Subira-Rios D., Koifman L., de Cassio Zequi S., Pontillo H. M., de Ribamar Rodrigues Calixto J., Silva R. C., Mark Smithers B., Garzon S., Haase O., Sommariva A., Fruscio R., Martins F., de Oliveira P. S., Sandri G. B. L., Clementi M., Astigueta J., Metwally I. H., Bharathan R., Jindal T., Nakamura Y., Mageed H. A., Jeevarajan S., Lay R. R., García-Perdomo H. A., González O. R., Ghodoussipour S., Gill I., Cacciamani G. E., Sotelo, R, Sayegh, A, Medina, L, Perez, L, Riva, A, Eppler, M, Gaona, J, Tobias-Machado, M, Spiess, P, Pettaway, C, Pompeo, A, Mattos, P, Wilson, T, Villoldo, G, Chung, E, Samaniego, A, Ornellas, A, Pinheiro, V, Brazão, E, Subira-Rios, D, Koifman, L, de Cassio Zequi, S, Pontillo, H, de Ribamar Rodrigues Calixto, J, Silva, R, Mark Smithers, B, Garzon, S, Haase, O, Sommariva, A, Fruscio, R, Martins, F, de Oliveira, P, Sandri, G, Clementi, M, Astigueta, J, Metwally, I, Bharathan, R, Jindal, T, Nakamura, Y, Mageed, H, Jeevarajan, S, Lay, R, García-Perdomo, H, González, O, Ghodoussipour, S, Gill, I, Cacciamani, G, Sotelo R., Sayegh A. S., Medina L. G., Perez L. C., Riva A. L., Eppler M. B., Gaona J., Tobias-Machado M., Spiess P. E., Pettaway C. A., Pompeo A. C. L., Mattos P. A. L., Wilson T. G., Villoldo G. M., Chung E., Samaniego A., Ornellas A. A., Pinheiro V., Brazão E. S., Subira-Rios D., Koifman L., de Cassio Zequi S., Pontillo H. M., de Ribamar Rodrigues Calixto J., Silva R. C., Mark Smithers B., Garzon S., Haase O., Sommariva A., Fruscio R., Martins F., de Oliveira P. S., Sandri G. B. L., Clementi M., Astigueta J., Metwally I. H., Bharathan R., Jindal T., Nakamura Y., Mageed H. A., Jeevarajan S., Lay R. R., García-Perdomo H. A., González O. R., Ghodoussipour S., Gill I., and Cacciamani G. E.

Published
2024

2. Validation of a blood-based sphingolipid panel for men with prostate cancer on active surveillance

Author

Gregg, J.R., primary, Irajizad, E., additional, Newcomb, L., additional, Wu, R., additional, Dennison, J., additional, Davis, J.W., additional, Pettaway, C., additional, Pisters, L., additional, Ward, J.F., additional, Chapin, B.F., additional, Chery, L., additional, Urkmez, A., additional, Troncoso, P., additional, Daniel, C.R., additional, Hahn, A.W., additional, Liu, M., additional, Zheng, Y., additional, Lin, D., additional, Hanash, S., additional, and Fahrmann, J., additional

Published
2024
Full Text
View/download PDF

4. 1310MO Neoadjuvant platinum-based chemotherapy (NAPC) for metastatic penile squamous cell carcinoma (PSCC): An international, multicenter, real-world study

Author

Chahoud, J., primary, Mustasam, A., additional, Rose, K.M., additional, Spiess, P.E., additional, Moses, K.L., additional, Master, V.A., additional, Nazha, B., additional, Zhuang, T.Z., additional, Schneider, A., additional, Marchetti, K., additional, Roussel, E., additional, Pham, R.T., additional, Zacharias, N., additional, Pagliaro, L., additional, Hernandez, C., additional, Montrose, J., additional, Alifrangis, C., additional, Albersen, M., additional, Protzel, C., additional, and Pettaway, C., additional

Published
2022
Full Text
View/download PDF

13. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative

Author

Bogaerts, J., Sydes, M.R., Keat, N., McConnell, A., Benson, A., Ho, A., Roth, A., Fortpied, C., Eng, C., Peckitt, C., Coens, C., Pettaway, C., Arnold, D., Hall, E., Marshall, E., Sclafani, F., Hatcher, H., Earl, H., Ray-Coquard, I., Paul, J., Blay, J.Y., Whelan, J., Panageas, K., Wheatley, K., Harrington, K., Licitra, L., Billingham, L., Hensley, M., McCabe, M., Patel, P.M., Carvajal, R., Wilson, R., Glynne-Jones, R., McWilliams, R., Leyvraz, S., Rao, S., Nicholson, S., Filiaci, V., Negrouk, A., Lacombe, D., Dupont, E., Pauporté, I., Welch, J.J., Law, K., Trimble, T., and Seymour, M.

Abstract

BACKGROUND: The past three decades have seen rapid improvements in the diagnosis and treatment of most cancers and the most important contributor has been research. Progress in rare cancers has been slower, not least because of the challenges of undertaking research. SETTINGS: The International Rare Cancers Initiative (IRCI) is a partnership which aims to stimulate and facilitate the development of international clinical trials for patients with rare cancers. It is focused on interventional--usually randomized--clinical trials with the clear goal of improving outcomes for patients. The key challenges are organisational and methodological. A multi-disciplinary workshop to review the methods used in ICRI portfolio trials was held in Amsterdam in September 2013. Other as-yet unrealised methods were also discussed. RESULTS: The IRCI trials are each presented to exemplify possible approaches to designing credible trials in rare cancers. Researchers may consider these for use in future trials and understand the choices made for each design. INTERPRETATION: Trials can be designed using a wide array of possibilities. There is no 'one size fits all' solution. In order to make progress in the rare diseases, decisions to change practice will have to be based on less direct evidence from clinical trials than in more common diseases.

Published
2015

14. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

Author

Al Olama, AA, Kote-Jarai, Z, Berndt, SI, Conti, DV, Schumacher, F, Han, Y, Benlloch, S, Hazelett, DJ, Wang, Z, Saunders, E, Leongamornlert, D, Lindstrom, S, Jugurnauth-Little, S, Dadaev, T, Tymrakiewicz, M, Stram, DO, Rand, K, Wan, P, Stram, A, Sheng, X, Pooler, LC, Park, K, Xia, L, Tyrer, J, Kolonel, LN, Le Marchand, L, Hoover, RN, Machiela, MJ, Yeager, M, Burdette, L, Chung, CC, Hutchinson, A, Yu, K, Goh, C, Ahmed, M, Govindasami, K, Guy, M, Tammela, TLJ, Auvinen, A, Wahlfors, T, Schleutker, J, Visakorpi, T, Leinonen, KA, Xu, J, Aly, M, Donovan, J, Travis, RC, Key, TJ, Siddiq, A, Canzian, F, Khaw, K-T, Takahashi, A, Kubo, M, Pharoah, P, Pashayan, N, Weischer, M, Nordestgaard, BG, Nielsen, SF, Klarskov, P, Roder, MA, Iversen, P, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Stanford, JL, Kolb, S, Holt, S, Knudsen, B, Coll, AH, Gapstur, SM, Diver, WR, Stevens, VL, Maier, C, Luedeke, M, Herkommer, K, Rinckleb, AE, Strom, SS, Pettaway, C, Yeboah, ED, Tettey, Y, Biritwum, RB, Adjei, AA, Tay, E, Truelove, A, Niwa, S, Choklcalingam, AP, Cannon-Albright, L, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Park, J, Sellers, T, Lin, H-Y, Isaacs, WB, Partin, AW, Brenner, H, Dieffenbach, AK, Stegmaier, C, Chen, C, Giovannucci, EL, Ma, J, Stampfer, M, Penney, KL, Mucci, L, John, EM, Ingles, SA, Kittles, RA, Murphy, AB, Pandha, H, Michael, A, Kierzek, AM, Blot, W, Signorello, LB, Zheng, W, Albanes, D, Virtamo, J, Weinstein, S, Nemesure, B, Carpten, J, Leske, C, Wu, S-Y, Hennis, A, Kibel, AS, Rybicki, BA, Neslund-Dudas, C, Hsing, AW, Chu, L, Goodman, PJ, Klein, EA, Zheng, SL, Batra, J, Clements, J, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Slavov, C, Kaneva, R, Mitev, V, Witte, JS, Casey, G, Gillanders, EM, Seminara, D, Riboli, E, Hamdy, FC, Coetzee, GA, Li, Q, Freedman, ML, Hunter, DJ, Muir, K, Gronberg, H, Nea, DE, Southey, M, Giles, GG, Severi, G, Cook, MB, Nakagawa, H, Wiklund, F, Kraft, P, Chanock, SJ, Henderson, BE, Easton, DF, Eeles, RA, Haiman, CA, Al Olama, AA, Kote-Jarai, Z, Berndt, SI, Conti, DV, Schumacher, F, Han, Y, Benlloch, S, Hazelett, DJ, Wang, Z, Saunders, E, Leongamornlert, D, Lindstrom, S, Jugurnauth-Little, S, Dadaev, T, Tymrakiewicz, M, Stram, DO, Rand, K, Wan, P, Stram, A, Sheng, X, Pooler, LC, Park, K, Xia, L, Tyrer, J, Kolonel, LN, Le Marchand, L, Hoover, RN, Machiela, MJ, Yeager, M, Burdette, L, Chung, CC, Hutchinson, A, Yu, K, Goh, C, Ahmed, M, Govindasami, K, Guy, M, Tammela, TLJ, Auvinen, A, Wahlfors, T, Schleutker, J, Visakorpi, T, Leinonen, KA, Xu, J, Aly, M, Donovan, J, Travis, RC, Key, TJ, Siddiq, A, Canzian, F, Khaw, K-T, Takahashi, A, Kubo, M, Pharoah, P, Pashayan, N, Weischer, M, Nordestgaard, BG, Nielsen, SF, Klarskov, P, Roder, MA, Iversen, P, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Stanford, JL, Kolb, S, Holt, S, Knudsen, B, Coll, AH, Gapstur, SM, Diver, WR, Stevens, VL, Maier, C, Luedeke, M, Herkommer, K, Rinckleb, AE, Strom, SS, Pettaway, C, Yeboah, ED, Tettey, Y, Biritwum, RB, Adjei, AA, Tay, E, Truelove, A, Niwa, S, Choklcalingam, AP, Cannon-Albright, L, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Park, J, Sellers, T, Lin, H-Y, Isaacs, WB, Partin, AW, Brenner, H, Dieffenbach, AK, Stegmaier, C, Chen, C, Giovannucci, EL, Ma, J, Stampfer, M, Penney, KL, Mucci, L, John, EM, Ingles, SA, Kittles, RA, Murphy, AB, Pandha, H, Michael, A, Kierzek, AM, Blot, W, Signorello, LB, Zheng, W, Albanes, D, Virtamo, J, Weinstein, S, Nemesure, B, Carpten, J, Leske, C, Wu, S-Y, Hennis, A, Kibel, AS, Rybicki, BA, Neslund-Dudas, C, Hsing, AW, Chu, L, Goodman, PJ, Klein, EA, Zheng, SL, Batra, J, Clements, J, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Slavov, C, Kaneva, R, Mitev, V, Witte, JS, Casey, G, Gillanders, EM, Seminara, D, Riboli, E, Hamdy, FC, Coetzee, GA, Li, Q, Freedman, ML, Hunter, DJ, Muir, K, Gronberg, H, Nea, DE, Southey, M, Giles, GG, Severi, G, Cook, MB, Nakagawa, H, Wiklund, F, Kraft, P, Chanock, SJ, Henderson, BE, Easton, DF, Eeles, RA, and Haiman, CA

Abstract

Genome-wide association studies (GWAS) have identified 76 variants associated with prostate cancer risk predominantly in populations of European ancestry. To identify additional susceptibility loci for this common cancer, we conducted a meta-analysis of > 10 million SNPs in 43,303 prostate cancer cases and 43,737 controls from studies in populations of European, African, Japanese and Latino ancestry. Twenty-three new susceptibility loci were identified at association P < 5 × 10(-8); 15 variants were identified among men of European ancestry, 7 were identified in multi-ancestry analyses and 1 was associated with early-onset prostate cancer. These 23 variants, in combination with known prostate cancer risk variants, explain 33% of the familial risk for this disease in European-ancestry populations. These findings provide new regions for investigation into the pathogenesis of prostate cancer and demonstrate the usefulness of combining ancestrally diverse populations to discover risk loci for disease.

Published
2014

15. Genome-Wide Association of Body Fat Distribution in African Ancestry Populations Suggests New Loci

Author

Liu, CT, Monda, KL, Taylor, KC, Lange, L, Demerath, EW, Palmas, W, Wojczynski, MK, Ellis, JC, Vitolins, MZ, Liu, S, Papanicolaou, GJ, Irvin, MR, Xue, L, Griffin, PJ, Nalls, MA, Adeyemo, A, Liu, J, Li, G, Ruiz-Narvaez, EA, Chen, WM, Chen, F, Henderson, BE, Millikan, RC, Ambrosone, CB, Strom, SS, Guo, X, Andrews, JS, Sun, YV, Mosley, TH, Yanek, LR, Shriner, D, Haritunians, T, Rotter, JI, Speliotes, EK, Smith, M, Rosenberg, L, Mychaleckyj, J, Nayak, U, Spruill, I, Garvey, WT, Pettaway, C, Nyante, S, Bandera, EV, Britton, AF, Zonderman, AB, Rasmussen-Torvik, LJ, Chen, YDI, Ding, J, Lohman, K, Kritchevsky, SB, Zhao, W, Peyser, PA, Kardia, SLR, Kabagambe, E, Broeckel, U, Chen, G, Zhou, J, Wassertheil-Smoller, S, Neuhouser, ML, Rampersaud, E, Psaty, B, Kooperberg, C, Manson, JAE, Kuller, LH, Ochs-Balcom, HM, Johnson, KC, Sucheston, L, Ordovas, JM, Palmer, JR, Haiman, CA, McKnight, B, Howard, BV, Becker, DM, Bielak, LF, Liu, Y, Allison, MA, Grant, SFA, Burke, GL, Patel, SR, Schreiner, PJ, Borecki, IB, Evans, MK, Taylor, H, Sale, MM, Howard, V, Carlson, CS, Rotimi, CN, Cushman, M, Harris, TB, Reiner, AP, Cupples, LA, North, KE, Fox, CS, Liu, CT, Monda, KL, Taylor, KC, Lange, L, Demerath, EW, Palmas, W, Wojczynski, MK, Ellis, JC, Vitolins, MZ, Liu, S, Papanicolaou, GJ, Irvin, MR, Xue, L, Griffin, PJ, Nalls, MA, Adeyemo, A, Liu, J, Li, G, Ruiz-Narvaez, EA, Chen, WM, Chen, F, Henderson, BE, Millikan, RC, Ambrosone, CB, Strom, SS, Guo, X, Andrews, JS, Sun, YV, Mosley, TH, Yanek, LR, Shriner, D, Haritunians, T, Rotter, JI, Speliotes, EK, Smith, M, Rosenberg, L, Mychaleckyj, J, Nayak, U, Spruill, I, Garvey, WT, Pettaway, C, Nyante, S, Bandera, EV, Britton, AF, Zonderman, AB, Rasmussen-Torvik, LJ, Chen, YDI, Ding, J, Lohman, K, Kritchevsky, SB, Zhao, W, Peyser, PA, Kardia, SLR, Kabagambe, E, Broeckel, U, Chen, G, Zhou, J, Wassertheil-Smoller, S, Neuhouser, ML, Rampersaud, E, Psaty, B, Kooperberg, C, Manson, JAE, Kuller, LH, Ochs-Balcom, HM, Johnson, KC, Sucheston, L, Ordovas, JM, Palmer, JR, Haiman, CA, McKnight, B, Howard, BV, Becker, DM, Bielak, LF, Liu, Y, Allison, MA, Grant, SFA, Burke, GL, Patel, SR, Schreiner, PJ, Borecki, IB, Evans, MK, Taylor, H, Sale, MM, Howard, V, Carlson, CS, Rotimi, CN, Cushman, M, Harris, TB, Reiner, AP, Cupples, LA, North, KE, and Fox, CS

Abstract

Central obesity, measured by waist circumference (WC) or waist-hip ratio (WHR), is a marker of body fat distribution. Although obesity disproportionately affects minority populations, few studies have conducted genome-wide association study (GWAS) of fat distribution among those of predominantly African ancestry (AA). We performed GWAS of WC and WHR, adjusted and unadjusted for BMI, in up to 33,591 and 27,350 AA individuals, respectively. We identified loci associated with fat distribution in AA individuals using meta-analyses of GWA results for WC and WHR (stage 1). Overall, 25 SNPs with single genomic control (GC)-corrected p-values<5.0×10-6 were followed-up (stage 2) in AA with WC and with WHR. Additionally, we interrogated genomic regions of previously identified European ancestry (EA) WHR loci among AA. In joint analysis of association results including both Stage 1 and 2 cohorts, 2 SNPs demonstrated association, rs2075064 at LHX2, p = 2.24×10-8 for WC-adjusted-for-BMI, and rs6931262 at RREB1, p = 2.48×10-8 for WHR-adjusted-for-BMI. However, neither signal was genome-wide significant after double GC-correction (LHX2: p = 6.5×10-8; RREB1: p = 5.7×10-8). Six of fourteen previously reported loci for waist in EA populations were significant (p<0.05 divided by the number of independent SNPs within the region) in AA studied here (TBX15-WARS2, GRB14, ADAMTS9, LY86, RSPO3, ITPR2-SSPN). Further, we observed associations with metabolic traits: rs13389219 at GRB14 associated with HDL-cholesterol, triglycerides, and fasting insulin, and rs13060013 at ADAMTS9 with HDL-cholesterol and fasting insulin. Finally, we observed nominal evidence for sexual dimorphism, with stronger results in AA women at the GRB14 locus (p for interaction = 0.02). In conclusion, we identified two suggestive loci associated with fat distribution in AA populations in addition to confirming 6 loci previously identified in populations of EA. These findings reinforce the concept that there are fat distr

Published
2013

26. The utility of PSA for detection of prostate cancer in men treated with dutasteride: Results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) study

Author

Andriole, G.L., primary, Bostwick, D., additional, Brawley, O., additional, Gomella, L., additional, Marberger, M., additional, Montorsi, F., additional, Pettaway, C., additional, Tammela, T., additional, Teloken, C., additional, Tindall, D., additional, Wilson, T.H., additional, Somerville, M., additional, Fowler, I., additional, and Rittmaster, R.S., additional

Published
2009
Full Text
View/download PDF

40. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.

Author

R. A. Kitties, Baffoe-Bonnie, A. B., Moses, T. Y., Robbins, C. M., Ahaghotu, C., Huusko, P., Pettaway, C., Vijayakumar, S., Bennett, J., Hoke, G., Mason, I., Weinrich, S., Trent, J. M., Collins, F. S., Mousses, S., Bailey-Wilson, J., Furbert-Harris, P., Dunston, G., Powell, I. J., and Carpten, J. D.

Subjects
PROSTATE cancer, CANCER patients, TUMORS, GENETIC polymorphisms, MALE reproductive organs, CANCER genetics, TUMOR suppressor genes
Abstract

Background: The EphB2 gene was recently implicated as a prostate cancer (PC) tumour suppressor gene, with somatic inactivating mutations occurring in ~10% of sporadic tumours. We evaluated the contribution of EphB2 to inherited PC susceptibility in African Americans (AA) by screening the gene for germline polymorphisms. Methods: Direct sequencing of the coding region of EphB2 was performed on 72 probands from the African American Hereditary Prostate Cancer Study (AAHPC). A case-control association analysis was then carried out using the AAHPC probands and an additional 183 cases of sporadic PC compared with 329 healthy AA male controls. In addition, we performed an ancestry adjusted association study where we adjusted for individual ancestry among all subjects, in order to rule out a spurious association due to population stratification. Results: Ten coding sequence variants were identified, including the K1019X (3055A→T) nonsense mutation which was present in 15.3% of the AAHPC probands but only 1.7% of 231 European American (EA) control samples. We observed that the 3055A→T mutation significantly increased risk for prostate cancer over twofold (Fisher's two sided test, p=0.003). The T allele was significantly more common among AAHPC probands (15.3%) than among healthy AA male controls (5.2%) (odds ratio 3.31; 95% confidence interval 1.5 to 7.4; p=0.008). The ancestry adjusted analyses confirmed the association. Conclusions: Our data show that the K1019X mutation in the EphB2 gene differs in frequency between AA and EA, is associated with increased risk for PC in AA men with a positive family history, and may be an important genetic risk factor for prostate cancer in AA. [ABSTRACT FROM AUTHOR]

Published
2006
Full Text
View/download PDF

45. African-American heredity prostate cancer study: A model for genetic research

Author

Powell, I. J., Carpten, J., Dunston, G., Kittles, R., Bennett, J., Hoke, G., Pettaway, C., Weinrich, S., Vijayakumar, S., Ahaghotu, C. A., Boykin, W., Mason, T., Royal, C., Baffoe-Bonnie, A., Joan Bailey-Wilson, Berg, K., Trent, J., and Collins, F.

Subjects
Male, Genetic Research, Models, Genetic, Genetic Linkage, Incidence, Prostatic Neoplasms, Syntaxin 1, Nerve Tissue Proteins, Middle Aged, Health Surveys, Sensitivity and Specificity, United States, Pedigree, Asian People, Chromosomes, Human, Pair 1, Risk Factors, Surveys and Questionnaires, Antigens, Surface, Humans, Genetic Predisposition to Disease, Research Article, Aged
Abstract

A genome-wide scan of high-risk prostate cancer families in North America has demonstrated linkage of a particular marker to Chromosome 1q (HPC1). An even greater proportion of African-American families have shown linkage to HPC1. Therefore, investigators at the National Human Genome Research Institute (NHGRI) in collaboration with Howard University and a predominantly African-American group of urologists established the African-American Hereditary Prostate Cancer (AAHPC) Study Network to confirm the suggested linkage of HPC in African Americans with a gene on Chromosome 1. Blood samples from recruited families were sent to Howard University for extraction of DNA. The DNA was sent to NHGRI at NIH where the genotyping and genetic sequence analysis was conducted. Genotype data are merged with pedigree information so that statistical analysis can be performed to establish potential linkage. From March 1, 1998, to June 1, 1999, a total of 40 African-American families have been recruited who met the study criteria. Preliminary results suggest that racial/ethnicity grouping may affect the incidence and extent of linkage of prostate cancer to specific loci. The importance of these findings lays in the future treatment of genetic-based diseases.

46. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

Author

Aa, Al Olama, Kote-Jarai Z, Si, Berndt, Dv, Conti, Schumacher F, Han Y, Benlloch S, Dj, Hazelett, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Do, Stram, Rand K, Wan P, Stram A, Sheng X, Lc, Pooler, Park K, Xia L, Tyrer J, Ln, Kolonel, Le Marchand L, Rn, Hoover, Mj, Machiela, Yeager M, Burdette L, Cc, Chung, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tl, Tammela, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Ka, Leinonen, Xu J, Aly M, Donovan J, Rc, Travis, Tj, Key, Siddiq A, Canzian F, Kt, Khaw, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Bg, Nordestgaard, Sf, Nielsen, Klarskov P, Ma, Røder, Iversen P, Sn, Thibodeau, Sk, Mcdonnell, Dj, Schaid, Jl, Stanford, Kolb S, Holt S, Knudsen B, Ah, Coll, Sm, Gapstur, Wr, Diver, Vl, Stevens, Maier C, Luedeke M, Herkommer K, Ae, Rinckleb, Ss, Strom, Pettaway C, Ed, Yeboah, Tettey Y, Rb, Biritwum, Aa, Adjei, Tay E, Truelove A, Niwa S, Ap, Chokkalingam, Cannon-Albright L, Cybulski C, Wokołorczyk D, Kluźniak W, Park J, Sellers T, Hy, Lin, Wb, Isaacs, Aw, Partin, Brenner H, Ak, Dieffenbach, Stegmaier C, Chen C, El, Giovannucci, Ma J, Stampfer M, Kl, Penney, Mucci L, Em, John, Sa, Ingles, Ra, Kittles, Ab, Murphy, Pandha H, Michael A, Am, Kierzek, Blot W, Lb, Signorello, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Sy, Wu, Hennis A, As, Kibel, Ba, Rybicki, Neslund-Dudas C, Aw, Hsing, Chu L, Pj, Goodman, Ea, Klein, Sl, Zheng, Batra J, Clements J, Spurdle A, Teixeira MR, Maia S, Slavov C, Kaneva R, Mitev V, Js, Witte, Casey G, Em, Gillanders, Seminara D, Riboli E, Fc, Hamdy, Ga, Coetzee, Li Q, Ml, Freedman, Dj, Hunter, Muir K, Gronberg H, Neal DE, Southey M, Gg, Giles, Severi G, Mb, Cook, Nakagawa H, Wiklund F, Kraft P, Sj, Chanock, Be, Henderson, Df, Easton, Ra, Eeles, and Ca, Haiman

49. Disparities in penile cancer

Author

Sharma, P., Zargar-Shoshtari, K., Pettaway, C. A., Matthew Schabath, Giuliano, A. R., and Spiess, P. E.

Catalog

Books, media, physical & digital resources
See catalog results